174 related articles for article (PubMed ID: 369375)
1. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage.
Braselton WE; Lin TJ; Ellegood JO; Mills TM; Mahesh VB
Am J Obstet Gynecol; 1979 Jan; 133(2):154-60. PubMed ID: 369375
[TBL] [Abstract][Full Text] [Related]
2. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
3. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
5. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)].
Sato N; Yanaihara T; Kanazawa M; Okinaga S; Arai K
Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):845-50. PubMed ID: 797581
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
[TBL] [Abstract][Full Text] [Related]
7. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
8. Long-term study of oral contraception with norethindrone 2 mg. and mestranol 0.1 mg.
Hutcherson WP; Schwartz HA; Weathers W
Fertil Steril; 1966; 17(1):59-67. PubMed ID: 5901012
[TBL] [Abstract][Full Text] [Related]
9. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
10. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
11. Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain.
Ladinsky H; Consolo S; Bianchi S; Peri G; Garattini S
Pharmacology; 1976; 14(3):232-9. PubMed ID: 986656
[TBL] [Abstract][Full Text] [Related]
12. The relative expressed estrogenicity of oral contraceptives.
Rooks WH; Kugler SL; Dorfman RI
Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.
Vose CW; Butler JK; Williams BM; Stafford JE; Shelton JR; Rose DA; Palmer RF; Breckenridge AM; Orme ML; Serlin MJ
Contraception; 1979 Feb; 19(2):119-27. PubMed ID: 428229
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclic progestin-estrogen therapy on sebum and acne in women.
Strauss JS; Pochi PE
JAMA; 1964 Nov; 190(9):815-9. PubMed ID: 12254865
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
17. Subdermal norethindrone pellets -- a method for contraception?
Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
19. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
White IN; Muller-Eberhard U
Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate.
Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
Contraception; 1978 Jul; 18(1):1-6. PubMed ID: 679682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]